Company
Luxa Biotechnology, LLC
Luxa Biotechnology, LLC has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| RPESC-RPE-4W | Phase 1/2 | Dry Age-related Macular Degeneration |
Latest
No recent events.
Follow Luxa Biotechnology, LLC on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.